Interaction of Macrophages and Mast Cells in the Production of Prostaglandins and Leukotrienes

  • B. A. Jakschik
  • Y. Wei
  • L. F. Owens

Abstract

It is well established that macrophages are very important in host defence, including the elimination of tumour cells. Macrophages contribute to host defence by phagocytosis, cytotoxic activity and immune regulation (Allison et al. 1978; Nathan et al. 1980). Mast cells are best characterized for their role in immediate hypersensitivity reactions. However, they also have other functions in host defence. They have been shown to phagocytose, though less efficiently than macrophages (Otani et al. 1982), and kill tumour cells (Tharp et al. 1986). With certain types of tumours, the mast cell number is greatly increased (Burtin 1986). The functional significance of mast cells in tumour control has been confirmed by the observation that the tumour incidence is increased in mast cell deficient mice (Burtin 1986). Mast cells also seem to be important in the initiation of inflammation, and certain tumours are associated with intense inflammatory reactions. We have observed that the influx of polymorphonuclear leukocytes in inflammation is markedly reduced in mast cell deficient mice (Qureshi and Jakschik 1987). Mast cells as well as macrophages are positioned in the tissue where noxious material may enter. They have the capacity to initiate processes which could eliminate unwanted material or cells.

Keywords

Polysaccharide Interferon Prostaglandin Macromolecule PGE2 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allison AC, Ferluga J, Prydz H, Schorlemmer HU (1978) The role of macrophage activation in chronic inflammation. Agents Action 8:27–35CrossRefGoogle Scholar
  2. Baggiolini M, Horisberger U, Ulrich M (1982) Phagocytosis of mast cell granules by mononuclear phagocytes, neutrophils and eosinophils during anaphylaxis. Int Arch Allergy Appl Immunol 67:219–226PubMedCrossRefGoogle Scholar
  3. Burtin C (1986) Mast cells and tumor growth. Ann Inst Pasteur Immunol. 137D:289–294PubMedGoogle Scholar
  4. Farrar WL, Humes JL (1985) The role of arachidonic acid metabolism in the activities of interleukin 1 and 2. J Immunol 135:1153–1159PubMedGoogle Scholar
  5. Ford-Hutchinson AW, Bray M, Doig MV, Shipley ME, Smith MJ (1980) Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264–265PubMedCrossRefGoogle Scholar
  6. Goodwin JS (1981) Prostaglandins and host defence in cancer. Med Clin North Am 65:829–843PubMedGoogle Scholar
  7. Humes JL, Burger S, Galavage M, Kuehl FA, Wrightman PD, Davies P, Bonney RJ (1980) The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal macrophages: possible mechanisms. J Immunol 124:2110–2116PubMedGoogle Scholar
  8. Humes JL, Sadowski S, Galavage M, Goldberg M, Subers E, Bonney RJ, Kuehl FA Jr (1982) Evidence for two sources of arachidonic acid for oxidative metabolism by mouse peritoneal macrophages. J Biol Chem 257:1591–1594PubMedGoogle Scholar
  9. Jakschik BA, Rengers TA, Pinski JR (1987a) Nature of the mast cell-macrophage interaction in immediate hypersensitivity. Adv Prostaglandin Thromboxane Leukotriene Res 17:180–185Google Scholar
  10. Jakschik BA, Wei YF, Rengers TA (1987b) Modulation of eicosanoid production due to mast cell-macrophage interaction. Adv Prostaglandin Thromboxane Leukotriene Res 16:141–152Google Scholar
  11. Kruger PG, Lagunoff D, Wan H (1980) Isolation of intact mast cell granules with intact membranes. Exp Cell Res 129:83–93PubMedCrossRefGoogle Scholar
  12. Nathan CF, Murray HW, Cohn ZA (1980) The macrophage as an effector cell. N Engl J Med 303:622–626PubMedCrossRefGoogle Scholar
  13. Otani I, Conrad HD, Carlo JR, Segal DM, Ruddy S (1982) Phagocytosis by rat peritoneal mast cells: independence of IgG Fc-mediated and C3-mediated signals. J Immunol 129:2109–2112PubMedGoogle Scholar
  14. Qureshi R, Jakschik BA (1987) The role of mast cells in inflammation. Fed Proc 46:985Google Scholar
  15. Rola-Pleszczynski M (1985) Immunoregulation by leukotrienes and other lipoxygenase metabolites. Immunol Today. 6:302–307CrossRefGoogle Scholar
  16. Rola-Pleszczynski M, Gagnon L (1986) Natural killer function modulated by leukotriene B4: Mechanism of action. Transplant Proc [Suppl 4] 18:44–48Google Scholar
  17. Rouzer AZ, Scott WA, Hamill AL, Cohn ZA (1980) Dynamics of leukotriene C4 production by macrophages. J Exp Med 152:1236–1247PubMedCrossRefGoogle Scholar
  18. Scott WA, Zrike JM, Kempe J, Cohn ZA (1980) Regulation of arachidonic acid metabolites in macrophages. J Exp Med 152:324–335PubMedCrossRefGoogle Scholar
  19. Tharp M, Thiele D, Charley M, Sullivan T (1986) Studies on the mechanism of mast cell killing of tumor cells. Fed Proc 45:850Google Scholar
  20. Wei Y, Heghinian K, Bell RL (1986) Contribution of macrophages to immediate hypersensitivity reaction. J Immunol 137:1993–2000PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • B. A. Jakschik
    • 1
  • Y. Wei
    • 1
  • L. F. Owens
    • 1
  1. 1.Department of PharmacologyWashington University School of MedicineSt. LouisUSA

Personalised recommendations